TCIM
NVLN

TIAA CREF Investment Management’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

TIAA CREF Investment Management’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-41,750
Closed -$146K – 3167
2018
Q1 		$146K Buy
41,750
+955
+2% +$3.34K ﹤0.01% 2998
2017
Q4 		$127K Hold
40,795
– – ﹤0.01% 3030
2017
Q3 		$287K Hold
40,795
– – ﹤0.01% 3004
2017
Q2 		$377K Buy
+40,795
New +$377K ﹤0.01% 2984